We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600536:SSEChina National Software & Service Company Limited Class A Analysis

Data as of 2026-06-15 - not real-time

CN¥30.19

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical outlook: The stock is trading at CNY 30.19, well below its 20‑day (CNY 36.53), 50‑day (CNY 37.54) and 200‑day (CNY 44.60) moving averages, indicating a sustained bearish momentum. The RSI 14 sits at 25.9, suggesting oversold conditions, while the MACD line is negative and the signal is bearish, reinforcing downside pressure. Current price hovers just above the identified support at CNY 28.58 and far below the resistance zone around CNY 41.44, leaving limited upside in the near term.
Fundamental outlook: Valuation metrics are starkly misaligned – a forward P/E of 158.9 versus an industry average of 36.8, and a price‑to‑book of 8×, while the discounted cash‑flow model caps fair value near CNY 4.09. Margins are weak (operating margin –12.4%, profit margin –0.7%) and ROE is only 4.8%, despite a respectable 10.8% revenue growth. High 30‑day volatility (57%) and a historic drawdown of –46% amplify the risk profile, especially amid heightened regulatory scrutiny of China’s tech sector.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD and low RSI indicating further downside
  • Severe overvaluation relative to DCF fair value

Medium Term

1–3 years
Cautious
Model confidence: 8/10

Key Factors

  • Persistently negative profitability margins
  • Forward P/E far above industry norm
  • Elevated volatility and large historical drawdown

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strategic state‑backed software portfolio
  • Potential policy support for domestic tech infrastructure
  • Current price still far above intrinsic fair value, requiring correction

Key Metrics & Analysis

Financial Health

Revenue Growth10.80%
Profit Margin-0.67%
P/E Ratio158.9
ROE4.77%
ROA1.26%
Debt/Equity21.44
P/B Ratio8.0
Op. Cash FlowCN¥452.7M
Free Cash FlowCN¥81.7M
Industry P/E36.8

Technical Analysis

TrendBearish
RSI25.9
SupportCN¥28.58
ResistanceCN¥41.44
MA 20CN¥36.53
MA 50CN¥37.54
MA 200CN¥44.60
MACDBearish
VolumeStable
Fear & Greed Index92.09

Valuation

Fair ValueCN¥4.09
GradeOvervalued
TypeValue

Risk Assessment

Beta0.01
Volatility57.09%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.